EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2018 update on diagnosis, risk-stratification and management
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2018 update on diagnosis, risk-stratification and management
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF HEMATOLOGY
Volume 93, Issue 7, Pages 953-962
Publisher
Wiley
Online
2018-07-09
DOI
10.1002/ajh.25112
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Response and survival benefit with chemoimmunotherapy in Epstein-Barr virus-positive diffuse large B-cell lymphoma
- (2017) Brady E. Beltran et al. HEMATOLOGICAL ONCOLOGY
- Reappraisal of Epstein-Barr virus (EBV) in diffuse large B-cell lymphoma (DLBCL): comparative analysis between EBV-positive and EBV-negative DLBCL with EBV-positive bystander cells
- (2017) Akiko Ohashi et al. HISTOPATHOLOGY
- Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
- (2017) Catherine Thieblemont et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical impact of serum survivin positivity and tissue expression of EBV-encoded RNA in diffuse large B-cell lymphoma patients treated with rituximab–CHOP
- (2017) Jung Yong Hong et al. Oncotarget
- The 2016 revision of the World Health Organization classification of lymphoid neoplasms
- (2016) S. H. Swerdlow et al. BLOOD
- The biology and treatment of plasmablastic lymphoma
- (2015) J. J. Castillo et al. BLOOD
- EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment
- (2015) A. Nicolae et al. BLOOD
- Frontline rituximab, cyclophosphamide, doxorubicin, and prednisone with bortezomib (VR-CAP) or vincristine (R-CHOP) for non-GCB DLBCL
- (2015) F. Offner et al. BLOOD
- Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma
- (2015) J. Kiyasu et al. BLOOD
- Abstract 2673: Idelalisib has activity at clinically achievable drug concentrations in a subset of ABC and GCB diffuse large B-cell lymphoma and transformed follicular lymphoma cell lines
- (2015) Jia Y. Liu et al. CANCER RESEARCH
- Prognostic significance of Epstein-Barr virus DNA detection in pretreatment serum in diffuse large B-cell lymphoma
- (2015) Akinao Okamoto et al. CANCER SCIENCE
- Large B-cell lymphoma arising in cardiac myxoma or intracardiac fibrinous mass: a localized lymphoma usually associated with Epstein–Barr virus?
- (2015) Cristian Aguilar et al. CARDIOVASCULAR PATHOLOGY
- Lenalidomide Combined With R-CHOP Overcomes Negative Prognostic Impact of Non–Germinal Center B-Cell Phenotype in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Phase II Study
- (2015) Grzegorz S. Nowakowski et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor
- (2015) James N. Kochenderfer et al. JOURNAL OF CLINICAL ONCOLOGY
- T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
- (2015) Daniel W Lee et al. LANCET
- Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy
- (2015) Zhiyu Liu et al. MODERN PATHOLOGY
- Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
- (2015) Wyndham H Wilson et al. NATURE MEDICINE
- PD-1 Blockade Can Restore Functions of T-Cells in Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma In Vitro
- (2015) Lina Quan et al. PLoS One
- Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma–is it necessary
- (2015) Chi Young Ok et al. Oncotarget
- Epstein-Barr virus positive diffuse large B-cell lymphoma predict poor outcome, regardless of the age
- (2015) Ting-Xun Lu et al. Scientific Reports
- EBV-positive diffuse large B-cell lymphoma in young adults: is this a distinct disease entity?
- (2014) J. Y. Hong et al. ANNALS OF ONCOLOGY
- Clinical outcome of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly in the rituximab era
- (2014) Ai Sato et al. CANCER SCIENCE
- Prevalence and Clinical Implications of Epstein-Barr Virus Infection in De Novo Diffuse Large B-Cell Lymphoma in Western Countries
- (2014) C. Y. Ok et al. CLINICAL CANCER RESEARCH
- High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial
- (2014) D Rossille et al. LEUKEMIA
- Clinical outcome of elderly patients with Epstein-Barr virus positive diffuse large B-cell lymphoma treated with a combination of rituximab and CHOP chemotherapy
- (2013) Jae-Sook Ahn et al. AMERICAN JOURNAL OF HEMATOLOGY
- EBV-positive diffuse large B-cell lymphoma of the elderly
- (2013) C. Y. Ok et al. BLOOD
- PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies
- (2013) B. J. Chen et al. CLINICAL CANCER RESEARCH
- Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins
- (2013) Catherine M. Bollard et al. JOURNAL OF CLINICAL ONCOLOGY
- Lenalidomide efficacy in activated B-cell-like subtype diffuse large B-cell lymphoma is dependent upon IRF4 and cereblon expression
- (2012) Ling-Hua Zhang et al. BRITISH JOURNAL OF HAEMATOLOGY
- Adoptive Transfer of Epstein-Barr Virus (EBV) Nuclear Antigen 1–Specific T Cells As Treatment for EBV Reactivation and Lymphoproliferative Disorders After Allogeneic Stem-Cell Transplantation
- (2012) Vanya Icheva et al. JOURNAL OF CLINICAL ONCOLOGY
- EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-kB activation
- (2012) Santiago Montes-Moreno et al. MODERN PATHOLOGY
- Epstein-Barr Virus-positive Diffuse Large B-cell Lymphomas of the Elderly
- (2011) Patrick Adam et al. ADVANCES IN ANATOMIC PATHOLOGY
- EBV-positive diffuse large B-cell lymphoma of the elderly: A case series from Peru
- (2011) Brady E. Beltran et al. AMERICAN JOURNAL OF HEMATOLOGY
- Histone deacetylase inhibitors are potent inducers of gene expression in latent EBV and sensitize lymphoma cells to nucleoside antiviral agents
- (2011) S. K. Ghosh et al. BLOOD
- Higher response to lenalidomide in relapsed/refractory diffuse large B-cell lymphoma in nongerminal center B-cell-like than in germinal center B-cell-like phenotype
- (2011) Francisco J. Hernandez-Ilizaliturri et al. CANCER
- EBV-Positive Diffuse Large B-Cell Lymphoma in Young Immunocompetent Individuals
- (2011) Brady E. Beltran et al. Clinical Lymphoma Myeloma & Leukemia
- Immune defence against EBV and EBV-associated disease
- (2011) Heather M Long et al. CURRENT OPINION IN IMMUNOLOGY
- CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group
- (2011) Michael Pfreundschuh et al. LANCET ONCOLOGY
- Geographic variation in the prevalence of Epstein–Barr virus-positive diffuse large B-cell lymphoma of the elderly: a comparative analysis of a Mexican and a German population
- (2011) Annegret Hofscheier et al. MODERN PATHOLOGY
- Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma of the Elderly: What We Know So Far
- (2011) J. J. Castillo et al. ONCOLOGIST
- Bortezomib Plus CHOP-Rituximab for Previously Untreated Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma
- (2010) Jia Ruan et al. JOURNAL OF CLINICAL ONCOLOGY
- Epstein–Barr virus as a prognostic factor inde novonodal diffuse large B-cell lymphoma
- (2010) Domingo Morales et al. LEUKEMIA & LYMPHOMA
- Critical role of PI3K signaling for NF- B-dependent survival in a subset of activated B-cell-like diffuse large B-cell lymphoma cells
- (2010) B. Kloo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
- (2009) H. E. Heslop et al. BLOOD
- Epstein-Barr virus–positive diffuse large B-cell lymphoma in elderly patients is rare in Western populations
- (2009) Sylvia Hoeller et al. HUMAN PATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started